Xuezhen Luo

1.1k total citations
41 papers, 861 citations indexed

About

Xuezhen Luo is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology. According to data from OpenAlex, Xuezhen Luo has authored 41 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Obstetrics and Gynecology, 26 papers in Reproductive Medicine and 15 papers in Immunology. Recurrent topics in Xuezhen Luo's work include Endometrial and Cervical Cancer Treatments (25 papers), Endometriosis Research and Treatment (17 papers) and Reproductive System and Pregnancy (13 papers). Xuezhen Luo is often cited by papers focused on Endometrial and Cervical Cancer Treatments (25 papers), Endometriosis Research and Treatment (17 papers) and Reproductive System and Pregnancy (13 papers). Xuezhen Luo collaborates with scholars based in China, Germany and United Kingdom. Xuezhen Luo's co-authors include Xiaojun Chen, Bingyi Yang, Da‐Jin Li, Chengcheng Ning, Weiwei Shan, Qin Zhu, Xiaoqiu Wang, Yingli Shi, Hongwei Zhang and Bingying Xie and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Xuezhen Luo

37 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuezhen Luo China	19	518	508	324	150	118	41	861
Marten van der Zee Netherlands	13	152 0.3×	149 0.3×	189 0.6×	206 1.4×	65 0.6×	15	552
Hyewon Chung South Korea	13	186 0.4×	170 0.3×	109 0.3×	177 1.2×	72 0.6×	26	538
Satoe Fujiwara Japan	14	210 0.4×	168 0.3×	63 0.2×	279 1.9×	63 0.5×	38	677
M. Nishida Japan	5	311 0.6×	174 0.3×	84 0.3×	133 0.9×	44 0.4×	9	453
Jamie Magrill Canada	8	420 0.8×	502 1.0×	28 0.1×	133 0.9×	34 0.3×	13	720
K Nanbu Japan	9	357 0.7×	59 0.1×	90 0.3×	359 2.4×	77 0.7×	11	670
Liangdan Tang China	15	193 0.4×	168 0.3×	33 0.1×	220 1.5×	31 0.3×	35	524
Valerie Fock Austria	12	47 0.1×	195 0.4×	230 0.7×	179 1.2×	22 0.2×	16	525
Elizabeth K. Lee United States	13	152 0.3×	64 0.1×	120 0.4×	205 1.4×	25 0.2×	34	662
Jinhua Quan Japan	10	99 0.2×	72 0.1×	69 0.2×	163 1.1×	72 0.6×	16	409

Countries citing papers authored by Xuezhen Luo

Since Specialization

Citations

This map shows the geographic impact of Xuezhen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhen Luo more than expected).

Fields of papers citing papers by Xuezhen Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezhen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhen Luo. The network helps show where Xuezhen Luo may publish in the future.

Co-authorship network of co-authors of Xuezhen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhen Luo. A scholar is included among the top collaborators of Xuezhen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhen Luo. Xuezhen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qi, Peng, Tianliang Yao, Jian Zhu, et al.. (2025). Clinical-grade AI model for molecular subtyping of endometrial cancer: a multi-center cohort study in China. Molecular Biomedicine. 6(1). 102–102.

Shan, Weiwei, et al.. (2024). Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia. Frontiers in Endocrinology. 14. 1286724–1286724. 2 indexed citations

Yang, Bingyi, Weiwei Shan, Wenyu Shao, et al.. (2023). Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study. Gynecologic Oncology. 174. 133–141. 5 indexed citations

Wang, Lulu, Hongwei Zhang, Li Sun, et al.. (2023). The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary. Journal of Ovarian Research. 16(1). 235–235.

Yang, Bingyi, Weiwei Shan, Wenyu Shao, et al.. (2022). 2022-RA-170-ESGO Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseIIstudy. International Journal of Gynecological Cancer. 32. A89–A90. 1 indexed citations

Lv, Qiaoying, et al.. (2022). Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients. Archives of Gynecology and Obstetrics. 306(4). 1135–1146. 1 indexed citations

Yang, Bingyi, Yuhui Xu, Qin Zhu, et al.. (2019). Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecologic Oncology. 153(1). 55–62. 71 indexed citations

Yang, Bingyi, Hongwei Zhang, Qin Zhu, et al.. (2018). Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients. Journal of Gynecologic Oncology. 29(3). e35–e35. 50 indexed citations

Luo, Xuezhen, et al.. (2018). The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. Journal of Gynecologic Oncology. 30(1). e13–e13. 47 indexed citations

10.

Lv, Qiaoying, Yali Cheng, Weiwei Shan, et al.. (2018). A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. Cancer Letters. 442. 137–147. 17 indexed citations

11.

Li, Jun, Qin Zhu, Bingyi Yang, et al.. (2018). Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 222. 151–154. 19 indexed citations

12.

Xie, Bingying, Bingyi Yang, Chengcheng Ning, et al.. (2017). Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage. Journal of Minimally Invasive Gynecology. 25(4). 724–729. 21 indexed citations

13.

Lv, Qiaoying, Bingying Xie, Bingyi Yang, et al.. (2017). Increased TET1 Expression in Inflammatory Microenvironment of Hyperinsulinemia Enhances the Response of Endometrial Cancer to Estrogen by Epigenetic Modulation of GPER. Journal of Cancer. 8(5). 894–902. 24 indexed citations

14.

Ning, Chengcheng, Bingying Xie, Lin Zhang, et al.. (2016). Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen. Cancer Research. 76(6). 1354–1366. 61 indexed citations

15.

Xie, Bingying, Qiaoying Lv, Chengcheng Ning, et al.. (2016). TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation. Biochemical and Biophysical Research Communications. 482(4). 857–862. 21 indexed citations

16.

Luo, Xuezhen, et al.. (2012). Analysis of insulin release pattern in patients with polycystic ovary syndrome and normal glucose tolerance. Zhonghua neifenmi daixie zazhi. 28(8). 635–637. 1 indexed citations

17.

Li, Ming‐Qing, Xuezhen Luo, Y. H. Meng, et al.. (2012). CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Human Reproduction. 27(7). 2107–2116. 73 indexed citations

18.

Wang, Yun, Jing Yu, Xuezhen Luo, et al.. (2010). Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells. Cellular and Molecular Immunology. 7(1). 51–60. 32 indexed citations

19.

Shi, Yingli, Xuezhen Luo, Xiao‐Yong Zhu, & Da‐Jin Li. (2007). Combination of 17β-estradiol with the environmental pollutant TCDD is involved in pathogenesis of endometriosis via up-regulating the chemokine I-309–CCR8. Fertility and Sterility. 88(2). 317–325. 21 indexed citations

20.

Shi, Yingli, Xuezhen Luo, Xiao‐Yong Zhu, et al.. (2006). Effects of combined 17β-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture. Human Reproduction. 21(4). 870–879. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact